Correlation Between Kelly Strategic and Invesco Nasdaq

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kelly Strategic and Invesco Nasdaq at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kelly Strategic and Invesco Nasdaq into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kelly Strategic Management and Invesco Nasdaq Biotechnology, you can compare the effects of market volatilities on Kelly Strategic and Invesco Nasdaq and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kelly Strategic with a short position of Invesco Nasdaq. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kelly Strategic and Invesco Nasdaq.

Diversification Opportunities for Kelly Strategic and Invesco Nasdaq

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between Kelly and Invesco is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Kelly Strategic Management and Invesco Nasdaq Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invesco Nasdaq Biote and Kelly Strategic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kelly Strategic Management are associated (or correlated) with Invesco Nasdaq. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invesco Nasdaq Biote has no effect on the direction of Kelly Strategic i.e., Kelly Strategic and Invesco Nasdaq go up and down completely randomly.

Pair Corralation between Kelly Strategic and Invesco Nasdaq

If you would invest  943.00  in Kelly Strategic Management on September 30, 2024 and sell it today you would earn a total of  0.00  from holding Kelly Strategic Management or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy1.56%
ValuesDaily Returns

Kelly Strategic Management  vs.  Invesco Nasdaq Biotechnology

 Performance 
       Timeline  
Kelly Strategic Mana 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kelly Strategic Management has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Kelly Strategic is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Invesco Nasdaq Biote 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Invesco Nasdaq Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Etf's fundamental drivers remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the ETF retail investors.

Kelly Strategic and Invesco Nasdaq Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kelly Strategic and Invesco Nasdaq

The main advantage of trading using opposite Kelly Strategic and Invesco Nasdaq positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kelly Strategic position performs unexpectedly, Invesco Nasdaq can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invesco Nasdaq will offset losses from the drop in Invesco Nasdaq's long position.
The idea behind Kelly Strategic Management and Invesco Nasdaq Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets